Aug 17, 2026 12:22PM
Aug 13, 2026 08:58AM
Jul 29, 2026 06:52AM
Jul 13, 2026 02:13AM
May 18, 2026 03:22PM
May 14, 2026 08:28AM
Apr 29, 2026 08:05AM Candel Therapeutics partners with EVERSANA for drug commercialization
Mar 18, 2026 07:57AM
Mar 17, 2026 08:05AM
Mar 13, 2026 06:10AM
Mar 12, 2026 03:57PM
Feb 19, 2026 04:02PM
Nov 21, 2025 12:24PM
Nov 13, 2025 04:50PM Candel Therapeutics, Inc. (CADL) Misses Q3 EPS by 3c
Nov 4, 2025 09:00AM
Oct 27, 2025 04:36PM
Oct 21, 2025 06:41AM
Oct 14, 2025 08:12AM
Oct 14, 2025 08:07AM
Oct 7, 2025 06:47AM
Sep 30, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Candel Therapeutics Inc. (CADL)
Aug 14, 2025 04:18PM
Aug 14, 2025 08:44AM
Jul 24, 2025 08:06AM
Jul 14, 2025 06:16AM
Jul 9, 2025 04:46PM
Jul 9, 2025 08:08AM
Jun 30, 2025 06:41AM H.C. Wainwright Assumes Candel Therapeutics Inc. (CADL) at Buy
Jun 24, 2025 09:06AM
Jun 23, 2025 08:05AM
Jun 6, 2025 08:07AM
May 28, 2025 08:05AM
May 22, 2025 05:08PM
May 13, 2025 05:11PM
Apr 23, 2025 04:13PM Candel Therapeutics (CADL) Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
Apr 11, 2025 06:38AM
Apr 1, 2025 08:02AM
Mar 26, 2025 04:05PM
Mar 20, 2025 08:01AM
Mar 17, 2025 06:43AM
Feb 25, 2025 08:01AM
Feb 20, 2025 05:01AM Citi Starts Candel Therapeutics Inc. (CADL) at Buy, PT $25
Jan 13, 2025 08:16AM
Dec 18, 2024 06:45AM
Dec 13, 2024 07:32AM
Dec 12, 2024 04:55PM
Dec 12, 2024 04:52PM
Dec 11, 2024 03:12PM
Dec 11, 2024 07:30AM Candel Therapeutics (CADL) Announces CAN-2409 Achieved Primary Endpoint in Phase 3 Prostate Cancer Trial, Showing Significantly Improved Disease-Free Survival
Aug 13, 2024 08:21AM

444,548 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All